Connect with us
European Gaming Congress 2024

Artificial Intelligence

SKAN Research Trust and Quadram Institute Bioscience to Develop Novel Microbial Therapies

Published

on

skan-research-trust-and-quadram-institute-bioscience-to-develop-novel-microbial-therapies

BENGALURU, India and LONDON, June 13, 2024 /PRNewswire/ — SKAN Research Trust, promoted by Indian entrepreneur Mr. Ashok Soota, and UK-based Quadram Institute Bioscience today announced that they will apply the cutting-edge TraDIS-Xpress platform to study the action of traditional medical compounds on bacteria, thereby aiding in the reformulation and development of novel antibacterial regimens.

TraDIS-Xpress is Quadram’s proprietary genetic sequencing platform that is in the forefront of efforts to uncover new antimicrobial agents and develop better prebiotics and probiotics for health promotion. 
The joint study titled the Application of TraDIS-Xpress in Microbiology for Healthy Living will be led by Quadram Principal Investigator, Prof. Mark Webber and SKAN’s Deputy Director, Dr Yogesh Shouche. The project is part of a larger Comprehensive Partnership Agreement between the two organizations that have ongoing international collaborations focused on gut health and developing gut microbial therapies to alleviate ageing and neurological diseases like Parkinsons.
An important aspect of the international collaboration is sharing the latest technologies in the study of the gut microbiome to augment Indian research capabilities. As part of this study, SKAN researchers will be trained on the TraDIS Xpress platform at the Quadram Institute in Norwich Research Park. This will facilitate the generation of data from large Indian cohorts that will aid in the development of India-specific therapies. Such data generation is also expected to hasten the TraDIS-Xpress platform’s development and amplify its applications’ scope.
Prof. Ian Charles, Director of Quadram Institute Bioscience, said, “I’m excited to see the cutting-edge genomic technology and expertise we have here in Quadram supporting our valued partners at the SKAN Research Trust to benefit the health of the people of India, and also further our fundamental understanding of the links between microbes and human wellbeing.”
Mr. Ashok Soota, Chairman & Managing Trustee of SKAN, said, “The research on novel microbial therapies raises our collaboration with QIB to a whole new level. We are grateful to Ian Charles for including SKAN as a partner in this transformational initiative.”
Prof. Mark Webber, Group Leader, Quadram Institute Bioscience, said, “This project highlights the potential of the TraDIS Xpress platform for identifying and understanding the genetic basis behind bacteria’s enormous capacity to adapt for survival. I’m looking forward to helping our colleagues in India deploy it to support their research.”    
Dr. Yogesh Shouche, Deputy Director, SKAN, said, “The three-year project will also study the mechanisms of drug resistance for key pathogens relevant to India and the action of selected food additives used in India on the growth of selected gut microbes.”
About SKAN Research Trust
SKAN is a Bengaluru-based not-for-profit medical research trust that leverages transformational technologies to develop new therapies for ageing and neurological ailments, cardiovascular diseases, diabetes remission and lifestyle related disorders. SKAN applies its expertise in gut microbiome, genomics, stem cells, molecular biology, biomarkers, immunotherapies, nutrition, and alternate therapies to uncover kinder and gentler treatment protocols for ailments. Bioinformatics at SKAN vigorously pursues cutting edge, artificial intelligence, machine learning and other advanced technologies to predict, pre-empt, diagnose, treat, and facilitate remission of medical disorders. The Mission statement of SKAN is “Transform the future of medicine.  Impacting millions of lives”.
Media contact: [email protected]: [email protected]
About Quadram Institute Bioscience
Quadram Institute Bioscience is a UK national science capability, and its mission is to deliver healthier lives through innovation in gut health, microbiology and food and its vision is focused on understanding how food and microbes interact to promote health and prevent disease. Interconnected research themes at the Quadram Institute on the Norwich Research Park, UK, deliver a pipeline of research in plants, microbiology, food, and health: microbes and food safety; the gut microbiome; and food innovation.
About TraDIS-Xpress
TraDIS-Xpress (transposon-directed insertion-site sequencing) is a high-resolution whole-genome assay that identifies which genes are likely to affect bacterial fitness in any given condition. This uses extremely dense, highly saturated mutant libraries to identify fitness differences at base pair resolution.
TraDIS-Xpress improves upon conventional transposon mutagenesis approaches through the use of outward-facing promoters. This allows the investigation of how gene expression, as well as gene deletion, affects bacterial fitness under a given growth condition. Additionally, it allows the investigation of essential genes that cannot be inactivated and therefore cannot be assayed by other approaches.
Photo: https://mma.prnewswire.com/media/2437959/Novel_Microbial_Therapies.jpgLogo: https://mma.prnewswire.com/media/2082007/4257624/SKAN_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/skan-research-trust-and-quadram-institute-bioscience-to-develop-novel-microbial-therapies-302172054.html

Continue Reading
Advertisement
Stake.com

Artificial Intelligence

InterSystems TrakCare and InterSystems IRIS for Health to underpin deployment of fully unified future-ready AI-driven healthcare ecosystem at NEOM

Published

on

intersystems-trakcare-and-intersystems-iris-for-health-to-underpin-deployment-of-fully-unified-future-ready-ai-driven-healthcare-ecosystem-at-neom

RIYADH, Saudi Arabia, July 24, 2024 /PRNewswire/ — InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, and NEOM, the sustainable development taking shape in northwest Saudi Arabia, today announced a groundbreaking partnership to revolutionize the healthcare experience within NEOM.

The partnership enables NEOM to deploy InterSystems TrakCare® across its healthcare facilities, which currently include one hospital and 41 clinics. TrakCare is a unified health information system that provides clinical, administrative, and financial information as a single source of truth for each patient and offers enhanced clinical decision support capabilities.
Additionally, by the end of 2024 InterSystems IRIS® for Health will centralize NEOM’s clinical application data to facilitate the development of innovative health programs. InterSystems IRIS for Health is a comprehensive, cloud-first digital health development platform that provides all the building blocks needed for Machine Learning and to work with practically any healthcare data standard, including HL7® FHIR®.
By adding IRIS for Health to their health ecosystem NEOM will significantly enhance the overall individual’s experience and move towards realizing NEOM’s ‘one patient, one record’ approach.
As a flexible and powerful healthcare information system TrakCare equips NEOM with extensive data capabilities, and as a digital health development platform IRIS for Health facilitates NEOM’s use of Artificial Intelligence (AI) driven technology. Combining these offerings empowers healthcare providers to make better informed decisions that optimize operations effectively for world-class healthcare services.
“This partnership marks a significant milestone in our mission to advance healthcare through innovative technology,” said Ali Abi Raad, Country Manager for the Middle East, India, and South Africa, InterSystems. “We are proud to support NEOM and their vision of building a digitally integrated healthcare ecosystem and becoming a global leader in health and well-being.”
“The partnership with InterSystems is a significant milestone in realizing our digital first and personalized prevention focused healthcare system. To realize this vision, we need flexible and data standards driven technology partners who are committed to our ‘one patient, one record’ approach.” – Dr Mahmoud Alyamany, Sector Head, NEOM Health & Wellbeing.
About InterSystems
Established in 1978, InterSystems is the leading provider of next-generation solutions for enterprise digital transformations in the healthcare, finance, manufacturing, and supply chain sectors. Its cloud-first data platforms solve interoperability, speed, and scalability problems for large organizations around the globe. InterSystems is committed to excellence through its award-winning, 24×7 support for customers and partners in more than 80 countries. Privately held and headquartered in Cambridge, Massachusetts, InterSystems has 39 offices in 28 countries worldwide. For more information, please visit InterSystems.com.
About NEOM
NEOM is an accelerator of human progress and a vision of what a new future might look like. It is a region in northwest Saudi Arabia on the Red Sea being built from the ground up as a living laboratory – a place where entrepreneurship will chart the course for this new future. It will be a destination and a home for people who dream big and want to be part of building a new model for exceptional livability, creating thriving businesses and reinventing environmental conservation.
NEOM will include hyperconnected, cognitive cities, ports and enterprise zones, research centers, sports and entertainment venues and tourist destinations. As a hub for innovation, entrepreneurs, business leaders and companies will come to research, incubate, and commercialize new technologies and enterprises in groundbreaking ways. Residents of NEOM will embody an international ethos and embrace a culture of exploration, risk-taking and diversity.
Photo – https://mma.prnewswire.com/media/2468338/ISC_Neom.jpg

View original content:https://www.prnewswire.co.uk/news-releases/intersystems-trakcare-and-intersystems-iris-for-health-to-underpin-deployment-of-fully-unified-future-ready-ai-driven-healthcare-ecosystem-at-neom-302205387.html

Continue Reading

Artificial Intelligence

Zesty Introduces Cloud Insights and Automation Platform To Ensure Optimization and Cloud Operational Excellence

Published

on

zesty-introduces-cloud-insights-and-automation-platform-to-ensure-optimization-and-cloud-operational-excellence

With prescriptive insights and AI automation for cloud infrastructure management for multiple CSPs, Zesty’s platform makes it simple to optimize cloud spending and performance, improve utilization rates, and create new opportunities for FinOps and DevOps teams
SAN MATEO, Calif., July 24, 2024 /PRNewswire/ — Zesty, a leader in automated cloud infrastructure management, announced today the launch of its Insights and Automation Platform. Designed to support a multi-cloud strategy and transform cloud challenges into opportunities for FinOps and DevOps teams, the platform optimizes cloud spending and improves utilization rates with prescriptive insights and automation, empowering companies to focus on innovation, not cloud or budget management.

As global innovation drives continuous exponential cloud growth, more than half of CIOs have reported an increase in their IT budget for this year specifically to enhance their capacity for financing new projects. Overseeing multiple vendors, intricate cost structures, and ever-evolving company needs have created enormous complications for companies as they scale and budget. While R&D teams prioritize leveraging cloud services to drive innovation and competitive advantage, Finance teams focus on controlling costs and ensuring budget adherence.
Zesty’s platform incorporates new insights to drastically simplify SMB and enterprise cloud cost management by prioritizing the highest value recommendations for FinOps teams. For example, the recommendations focused on reducing unused resources alone can help companies cut costs by 7%, which in some cases represents millions of dollars annually. The platform also hosts Zesty’s AI-driven flagship solutions, Commitment Manager and Zesty Disk, which automatically scale cloud resources up and down and identify potential savings across services. Zesty’s integration of insights and automation ensures that cloud investments consistently align with evolving business objectives with even greater efficiency and savings.
“CIOs are constantly exploring avenues to finance new projects. The Zesty Insights and Automation Platform will play a pivotal role in identifying areas of waste and help to free those funds for innovative projects. Machine learning capabilities and predictive analytics are driving serious returns for FinOps teams, with some of our customers recovering over a million dollars a year from cloud waste and using that to amplify innovation,” said Maxim Melamedov, CEO and Co-Founder of Zesty. “Our mission is to help businesses easily eliminate cloud-related waste in all its forms, financial, cloud resources, environmental, and time. Our platform comes at a critical time given the industry’s urgent need for effective financial management of cloud operations. Companies across all industries are desperate for a guide on their FinOps journey, and we are excited to be able to help.”
Zesty sets a new standard for the fragmented FinOps industry, providing a unified and efficient approach to cloud management, transforming visibility into action with prescriptive insights and automation, optimizing services such as AWS’ EC2, EBS, RDS, S3, ELB, EIP, and Azure’s Virtual Machines. Fueling its commitment to enhancing cloud infrastructure efficiency, Zesty manages billions in AWS contracts. Zesty’s customer-centric approach earned the company a near-perfect (4.9/5) CSAT (Customer Satisfaction Score) in 2023.
To learn more about Zesty’s Insights and Automation Platform or to book a demo, click here.
About Zesty
Zesty helps organizations accelerate innovation with its cloud infrastructure optimization platform. Powered by machine learning, Zesty provides FinOps and DevOps teams with prescriptive insights and automation to achieve the ideal utilization of cloud resources and enables CIOs to balance operational excellence and costs. Zesty’s optimization platform helps companies efficiently allocate resources for applications, with solutions for compute, storage, containers, databases, and more, saving time and money.
Founded in 2019, Zesty was built with the vision of making the cloud more affordable and accessible while reducing waste. With offices in San Mateo, Tel Aviv, Kiev, New York, and London, Zesty supports thousands of organizations, helping them get maximum value out of their cloud infrastructure. To learn more, visit https://zesty.co/.
Media Contact Kate Schoenstadt [email protected] IL: +972(0)-54-7776684
 

View original content:https://www.prnewswire.co.uk/news-releases/zesty-introduces-cloud-insights-and-automation-platform-to-ensure-optimization-and-cloud-operational-excellence-302205185.html

Continue Reading

Artificial Intelligence

Zenoo calls for collaboration to tackle AI fraud in banking

Published

on

zenoo-calls-for-collaboration-to-tackle-ai-fraud-in-banking

CAMBRIDGE, England, July 24, 2024 /PRNewswire/ — UK technology company Zenoo warns the use of AI in banking fraud is just getting started – and collaboration with AI specialists is required to stem its flow.

Cambridge-based Zenoo – whose clients include London Stock Exchange, Experian, Transunion and NASA – supplies digital onboarding and protection from financial crime for businesses and has issued a warning to the banking community that the malevolent use of AI will only become more sophisticated and prevalent in the future.
Zenoo UK managing director George Taylor said: “It’s an enormous concern how quickly and significantly AI is being innovated to assist in banking fraud. In particular, social engineering attacks to steal personal information, enable identity theft and unauthorised access to bank accounts, is becoming remarkably advanced.”
Key areas of concern include Psychographic Profiling – where AI will analyse extensive data to create detailed psychographic profiles of individuals, tailoring social engineering attacks to exploit specific psychological traits – and Manipulative Interactions where the rising use of chatbots and virtual assistants in banking will be taken advantage of to engage in prolonged, convincing interactions with targets to extract sensitive information or induce them to perform actions that compromise their security.
Taylor is calling for banking to respond to the AI threat with AI too by collaborating with AI defence systems that can learn and adapt in real-time to detect and respond to emerging threats and machine learning models to identify and predict potential fraud based on evolving patterns and behaviours.
He adds: “The key word in combatting the AI threat is ‘collaboration’. Here at Zenoo we partner with cutting edge providers of the latest AI deepfake detection solutions which can be easily integrated into existing or new customer on boarding flows to combat fraud. We must take advantage of those specialists who are analysing and responding to the AI threat on a daily basis”.
Visit Zenoo to learn more or book a demo.
About Zenoo
Zenoo specialises in the remote onboarding of customers for international companies to help them improve their conversion rates, breaking down barriers and making it easier for their customers to open accounts online. Visit partner.zenoo.com for further information. 
Media enquiriesContact Bruce Ackland on +44 7884 076548 or email [email protected] 

View original content:https://www.prnewswire.co.uk/news-releases/zenoo-calls-for-collaboration-to-tackle-ai-fraud-in-banking-302205333.html

Continue Reading

Trending